Asian biopharmaceutical firm SeriTech Co Ltd will set up its European subsidiary in Barcelona from the second quarter of 2021.

SeriTech Co Ltd specialises in extracting natural silk proteins, which have been scientifically proven for biomedical, therapeutic and cosmetic uses (biocompatibility with cardiac tissue, cardiovascular grafts, Alzheimer treatments, vaccines, etc.). They have also developed innovative transdermal delivery technology using microneedling.

One of the company’s first steps here has been to join CataloniaBio & HealthTech: “It is a highly active cluster, where we hope to broaden our alliances with companies in Catalonia, particularly in the field of biomedical drugs,” explains Richard Joye, co-founder and CEO of SeriTech Europe.

SeriTech Europe is also preparing to open a Series A round of funding to kick off its ambitious R&D programme.

Photo: Richard Joye, CEO of SeriTech Europe, and Luisa Sugisawa, head of Business Development - © SeriTech Co Ltd

Want to know more about SeriTech? We recommend this video of CataloniaBio & HealthTech interviewing them: